Breeding stocks continued to strengthen and aonong biology rose by the limit

Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital

“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”

Stem-cell Firm Hemacell Completes Pre-Series A+ Funding Round

Platelets play a crucial role in the coagulation process in vivo. However, platelets used in clinical practice mainly come from free donations and are in extreme shortage. Using stem cells to produce platelets in vitro is expected to solve this unmet clinical need.

InnoCare Pharma Gets Phase II Clinical Trial Approval for Monjuvi in China

It will be the first tafasitamab-based treatment for diffuse large B-cell lymphoma (DLBCL) in China if successful.

Healthcare Content Provider VanMul Receives Angle Round Funding

VanMul Health, a Chinese healthcare social media content provider, has received CNY 5 million in angel round funding. The company which founded less than a year ago, is taking a different approach to healthcare content on social media, forming deep partnerships with companies such as Douyin, Tencent, Roche, and Merck & Co.

Wens Foodstuff Forecasts Net Profit to Double YoY in 1H2020

Agricultural livestock is a sector of immense size, growth and complexity in China. As of 2019, Wens Foodstuff had achieved the largest sales volume of hogs and broilers among China's listed companies.